DARE

Daré Bioscience Inc.

Price

$0.74

return (12m)

-65.14%

p/e

-1.04

p/bv

-20.48

DIVIDEND YIELD

0.00%

DARE price

Daré Bioscience

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment DARE

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-0.15%

3 months

-64.47%

1 year

-65.14%

2 years

-77.94%

5 years

-96.03%

10 years

-99.12%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals DARE

Valuation

P/E

-1.04

Sector 1.07

Industry 3.44

P/BV

-20.48

Sector 1.86

Industry 2.12

P/Revenue (PSR)

33.54

Sector 1.54

Industry 1.69

EV/EBITDA

0.48

Sector -45.27

Industry 1.81

EV/EBIT

0.39

Sector -48.49

Industry -3.96

P/EBITDA

-1.28

Sector -31.51

Industry -53.51

P/EBIT

-1.03

Sector -42.93

Industry -50.81

P/Total Assets

0.51

Sector 0.85

Industry 0.94

P/Net Current Assets

-1.84

Sector -25.71

Industry -10.60

P/Working Capital

-48.40

Sector -4.14

Industry 2.66

EPS

-0.74

Sector -0.70

Industry -0.60

BVPS

-0.04

Sector 4.52

Industry 4.74

Efficiency

Gross Margin

-64.33%

Sector 49.51%

Industry 50.68%

EBITDA Margin

-1,274.47%

Sector -280.81%

Industry -57.47%

EBIT Margin

-100.00%

Sector -19.82%

Industry -25.80%

Net Profit Margins

-100.00%

Sector -24.01%

Industry -29.17%

Asset Turnover

0.01

Sector 0.13

Industry 0.15

Profitability

ROE

1,962.14%

Sector -23.78%

Industry -22.30%

ROA

-49.12%

Sector -24.20%

Industry -24.15%

ROIC

-50.60%

Sector -584.46%

Industry -96.49%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.99

Sector 1.91

Industry 1.98

Net Debt / EBITDA

5.27

Sector -23.21

Industry -2.21

Net Debt / EBIT

4.25

Sector -17.93

Industry -1.50

Net Debt / Equity

22.53

Sector -0.68

Industry -0.29

Gross Debt / Equity

0.00

Sector -0.72

Industry -0.82

Equity/Assets

-0.03

Sector 0.46

Industry 0.47

Liabilities/Assets

1.03

Sector 0.50

Industry 0.52

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-22.26%

Sector -

Industry -

Fundamentals DARE

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
DARE Daré Bioscience Inc.	$0.74	-65.14%	0.00%	-1.04	-20.48	1,962.14%	-100.00%
ABT Abbott Laboratories	$102.20	-19.92%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$92.07	0.39%	3.28%	21.29	2.19	10.29%	13.93%
BSX Boston Scientific Corp.	$43.13	-54.80%	0.00%	17.05	2.51	14.73%	17.49%
TMDX TransMedics Group Inc.	$79.38	-26.01%	0.00%	18.01	5.27	29.28%	22.69%
RMD ResMed Inc.	$234.61	-12.84%	1.07%	21.81	5.05	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$521.27	-15.40%	0.00%	35.95	25.41	70.67%	25.03%
COHR Coherent Inc.	$283.44	155.12%	0.00%	74.48	5.34	7.16%	11.31%
SYK Stryker Corp.	$281.76	-21.68%	1.27%	28.21	4.38	15.55%	14.43%
PHG Koninklijke Philips NV	$24.82	-5.61%	4.20%	17.81	1.74	9.80%	6.30%
INMD InMode Ltd.	$14.33	-6.13%	0.00%	10.78	1.33	12.32%	20.69%
BDX Becton Dickinson and Company	$187.39	2.94%	2.30%	53.38	2.06	3.85%	6.29%
DXCM DexCom Inc.	$85.21	30.85%	0.00%	32.03	12.21	38.14%	20.12%
EW Edwards Lifesciences Corp.	$85.60	15.77%	0.00%	47.85	4.48	9.37%	15.43%
ALGN Align Technology Inc.	$141.41	12.41%	0.00%	25.13	2.46	9.77%	9.99%
SNN Smith & Nephew PLC	$27.86	-17.87%	2.88%	20.20	4.39	21.74%	9.20%
IRMD iRadimed Corporation	$89.76	26.66%	1.46%	48.20	10.92	22.66%	26.70%
ZBH Zimmer Biomet Holdings Inc.	$92.30	-1.26%	1.08%	21.13	1.35	6.39%	9.48%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

DARE - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Daré Bioscience

Daré Bioscience Inc.

Average Investor10 user rating

4.0 (0 people)

United States

21 years

Founded: 2005

2014

Time since IPO - 12 years

23

Employees

Daré Bioscience Inc. (United States) is listed on the Nasdaq and has a market capitalization of $11.47 million, with shareholders equity totaling $-560.00 Thousand.

The company employs approximately 23 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Daré Bioscience Inc. reported $342.00 Thousand in revenue, generating net income of $-10.99 million.

Key financial metrics include a P/E ratio of -1.04, a price-to-book (P/B) ratio of -20.48, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker DARE.

Market cap

$11.47 million

Net worth

$-560.00 Thousand

$-560,000.00

Assets

$22.37 million

$22,370,000.00

Total Shares Outstanding

14.89 million

14,889,000

Average Daily Trading Volume

$605.70 Thousand

$605,697.34

Sector

Health

Industry

Medical Supplies and Equipment

DARE

DARE revenue and profits

Financial Results DARE

DRAG THE FRAME TO SEE MORE DATA

DARE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$87.73 16,27% (12M)

P/E

22.64

3.07%

ROE

6.12%

P/BV

1.39

CI - Cigna

$283.40 --1,90% (12M)

P/E

10.91

2.19%

ROE

16.04%

P/BV

1.75

CNC - Centene

$69.20 90,32% (12M)

P/E

-6.39

0.00%

ROE

-22.53%

P/BV

1.44

HUM - Humana

$424.68 59,34% (12M)

P/E

40.85

0.81%

ROE

6.63%

P/BV

2.71

SNY - Sanofi

$39.43 --16,02% (12M)

P/E

3.76

4.41%

ROE

18.43%

P/BV

0.69

JNJ - Johnson & Johnson

$246.60 32,11% (12M)

P/E

29.77

2.03%

ROE

24.76%

P/BV

7.37

LLY - Eli Lilly

$1,168.32 43,48% (12M)

P/E

39.18

0.57%

ROE

78.84%

P/BV

30.89

HCA - HCA Healthcare

$460.26 12,61% (12M)

P/E

14.42

0.68%

ROE

-213.15%

P/BV

-30.74